Hedge Fund - Cormorant Asset Management
Eagle Pharmaceuticals Inc. (EGRX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2017 - Q4 (2017-12-31) | $0 | 0% | 0 | $55.65 |
| 2 | 2017 - Q3 (2017-09-30) | $11,928,000 | 2.1% | 200,000 | $60.49 |
| 3 | 2017 - Q2 (2017-06-30) | $15,778,000 | 2.61% | 200,000 | $81.78 |
| 4 | 2017 - Q1 (2017-03-31) | $16,588,000 | 2.4% | 200,000 | $74.35 |
| 5 | 2016 - Q4 (2016-12-31) | $32,529,000 | 4.38% | 410,000 | $72.64 |
| 6 | 2016 - Q3 (2016-09-30) | $31,920,000 | 3.51% | 455,995 | $55.40 |
| 7 | 2016 - Q2 (2016-06-30) | $19,628,000 | 2.78% | 505,995 | $41.64 |
| 8 | 2016 - Q1 (2016-03-31) | $20,250,000 | 1.02% | 500,000 | $63.45 |
| 9 | 2015 - Q4 (2015-12-31) | $35,468,000 | 4.24% | 400,000 | $78.96 |
| 10 | 2015 - Q3 (2015-09-30) | $22,209,000 | 3.54% | 300,000 | $83.20 |
| 11 | 2015 - Q2 (2015-06-30) | $24,258,000 | 3.22% | 300,000 | $65.14 |
| 12 | 2015 - Q1 (2015-03-31) | $30,014,000 | 4.63% | 716,500 | $28.37 |
| 13 | 2014 - Q4 (2014-12-31) | $6,200,000 | 0.95% | 400,000 | $12.77 |
The displayed share prices are average quarterly stock market prices.